Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Goldberg

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Patterns of failure after the multimodality treatment of uterine papillary serous carcinomaBrij M Sood, Joan Jones, Sajel Gupta, et al.
Investigational New Drugs|May 10, 2006
A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancersSanjay Goel, Kavita Desai, Manuel Macapinlac, et al.
Investigational New Drugs|January 2, 2007
Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancersSanjay Goel, Kavita Desai, Sirisha Karri, et al.
Brain Injury|June 9, 2018
Pain and chronic mild traumatic brain injury in the US military population: a Chronic Effects of Neurotrauma Consortium studyMichelle R Hoot, Harvey S Levin, Austin N Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of ixabepilone: a first in class epothilone B analogue in late-phase clinical developmentSanjay Goel, Marvin Cohen, S Nilgün Cömezoglu, et al.
Gut|February 11, 2022
Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trialChristina M Brennan, Sandeep Nadella, Xiang Zhao, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
International Journal of Radiation Oncology, Biology, Physics|August 12, 2003
Patterns of failure after the multimodality treatment of uterine papillary serous carcinomaBrij M Sood, Joan Jones, Sajel Gupta, et al.
Investigational New Drugs|May 10, 2006
A phase I safety and dose escalation trial of docetaxel combined with GEM231, a second generation antisense oligonucleotide targeting protein kinase A R1alpha in patients with advanced solid cancersSanjay Goel, Kavita Desai, Manuel Macapinlac, et al.
Investigational New Drugs|January 2, 2007
Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancersSanjay Goel, Kavita Desai, Sirisha Karri, et al.
Brain Injury|June 9, 2018
Pain and chronic mild traumatic brain injury in the US military population: a Chronic Effects of Neurotrauma Consortium studyMichelle R Hoot, Harvey S Levin, Austin N Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of ixabepilone: a first in class epothilone B analogue in late-phase clinical developmentSanjay Goel, Marvin Cohen, S Nilgün Cömezoglu, et al.
Gut|February 11, 2022
Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trialChristina M Brennan, Sandeep Nadella, Xiang Zhao, et al.
Pageof 4